Bringing prevention in geriatrics: Evidences from cardiovascular medicine supporting the new challenge

Experimental Gerontology

Volumn 48, Issue 1, 2013, Pages 64-68

  Scuteri, Angelo ^a   Lakatta, Edward G ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Arterial aging; Arterial stiffness; Cardiovascular disease; Cognitive impairment; Dementia; Prevention

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II;

AGING; ARTERIAL AGING; ARTICLE; BLOOD VESSEL PARAMETERS; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; DEMENTIA; DIABETES MELLITUS; GERIATRICS; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; RISK MANAGEMENT;

AGED; AGING; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; EVIDENCE-BASED MEDICINE; HUMANS; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84872021248     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2012.02.009     Document Type: Article

References (71)

1. Basso N., Cini Pietrelli A.R., Ferder L., Terragno N.A., Inserra F. Protective effect of long-term angiotensin II inhibition. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H1351-H1358.
2. Bertoni A.G., Krop J.S., Anderson G.F., Brancati F.L. Diabetes-related morbidity and mortality in a national sample of U.S. elders. Diabetes Care 2002, 25:471-475.
3. Bowen R.L., Atwood C.S. Living and dying for sex. A theory of aging based on the modulation of cell cycle signaling by reproductive hormones. Gerontology 2004, 50:265-290.
4. Caplan G.A. A Conceptual Model for Primary Prevention: Principles of Preventive Psychiatry 1964, Basic Books, New York NY.
5. Centers for Disease Control and Prevention Trends in aging - United States and worldwide. MMWR Morb. Mortal. Wkly Rep. 2003, 52:101-106.
6. Comfort A. Feasibility in age research. Nature 1968, 217:320-322.
7. Reducing Risks for Mental Disorders: Frontiers for Preventive Intervention Research 1994, Committee on Prevention of Mental Disorders; Division of Biobehavioral Sciences and Mental Disorders, National Academy Press, Washington, DC. P.J. Mrazek, R.J. Haggerty (Eds.).
8. Convanico V., De Caprio L., Vigorito C., et al. Differences in blood pressure profile between young and elderly hypertensive patients. J. Hum. Hypertens. 1990, 4:405-409.
9. Dufouil C., Chalmers J., Coskun O., Besancon V., Bousser M.G., Guillon P., MacMahon S., Mazoyer B., Neal B., Woodward M., Tzourio-Mazoyer N., Tzourio C. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 2005, 112:1644-1650.
10. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 2001, 285:2486-2497. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).
11. Ford E.S., Mokdad A.H., Giles W.H., Mensah G.A. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 2003, 107:2185-2189.
12. Forette F., Seux M.I., Staessen J.A., Thijs L., Birkenhager W.H., Babarskiene M.R., Babeanu S., Bossini A., Gil-Extremera B., Girerd X., Laks T., Lilov E., Moisseyev V., Tuomilehto J., Vanhanen H., Webster J., Yodfat Y., Fagard R. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998, 352:1347-1351.
13. Franco O.H., Massaro J.M., Civil J., Cobain M.R., O'Malley B., D'Agostino R. Trajectoreis of entering the metabolic syndrome. The Framingham Heart Study. Circulation 2009, 120:1943-1950.
14. Freimer N., Sabatti C. The human phenome project. Nat. Genet. 2003, 34:15-21.
15. Ganau A., Saba P.S., Roman M.J., de Simone G., Realdi G., Devereux R.B. Aging induces left ventricular concentric remodelling in normotensive subjects. J. Hypertens. 1995, 13:1818-1822.
16. Gerstein H.C., Miller M.E., Byington R.P., for the Action to Control Cardiovascular Risk in Diabetes Study Group, et al. Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 2008, 358:2545-2559.
17. Terrera G.M., Brayne C., Matthews F. One size fits all? Why we need more sophisticated analytical methods in the explanation of trajectories of cognition in older age and their potential risk factors. Int. Psychogeriatr. 2010, 22:291-299. the CC75C Study Collaboration Group2.
18. Gorelick P.B., Scuteri A., Black S.E., DeCarli C., Greenberg S.M., Iadecola C., Launer L.J., Laurent S., Lopez O.L., Nyenhuis D., Petersen R.C., Schneider J.A., Tzourio C., Arnett D.K., Bennett D.A., Chui H.C., Higashida R.T., Lindquist R., Nilsson P.M., Roman G.C., Sellke F.W., Seshadri S. Vascular contributions to cognitive impairment and dementia, 2011. A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42:2672-2713. on behalf of the American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia, Epub 2011 Jul 21.
19. Hatazawa J., Shimosegawa E., Osaki Y., Ibaraki M., Oku N., Hasegawa S., Nagata K., Hirata Y., Miura Y. Long-term angiotensin-converting enzyme inhibitor perindopril therapy improves cerebral perfusion reserve in patients with previous minor stroke. Stroke 2004, 35:2117-2122.
20. Hoa A.J., Rajib C.A., Beckerd J.T., Lopezf O.L., Kuller L.H., Hua X., Lee S., Hibar D., Dinov I.D., Stein J.L., Jack C.R.J., Weiner M.J., Toga A.W., Thompson P.M. Obesity is linked with lower brain volume in 700AD and MCI patients. Neurobiol. Aging 2010, 31:1326-1339. the Cardiovascular Health Study, the ADNIthe ADNI.
21. Hughes G. Changes in taste sensitivity with advancing age. Gerontol. Clin. (Basel) 1969, 11:224-230.
22. Jacobsen J.C., Mulvany M.J., Holstein-Rathlou N.H. A mechanism for arteriolar remodeling based on maintenance of smooth muscle cell activation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 294:R1379-R1389.
23. Jacobson A., Yan C., Gao Q., Rincon-Skinner T., Rivera A., Edwards J., Huang A., Kaley G., Sun D. Aging enhances pressure-induced arterial superoxide formation. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H1344-H1350.
24. Jellinger K.A. Morphologic diagnosis of "vascular dementia" - a critical update. J. Neurol. Sci. 2008, 270:1-12.
25. Kalaria R.N., Maetre G.E., Arizaga R., Friedland R.P., Galasko D., Hall K., Luchsinger J.A., Ogunniyi A., Perry E.K., Potocnik F., Stewart R., Wimo A., Zhang Z., Antuono P. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 2008, 7:812-826.
26. Kannel W.B. Coronary heart disease risk factors in the elderly. Am. J. Geriatr. Cardiol. 2002, 11:101-107.
27. Klingbeil A.U., Schneider M., Martus P., Messerli F.H., Schmieder R.E. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am. J. Med. 2003, 115:41-46.
28. Lamar M., Resnick S.M., Zonderman A.B. Longitudinal changes in verbal memory in older adults: distinguishing the effects of age from repeat testing. Neurology 2003, 60:82-86.
29. Laurent S., Cockcroft J., Van Bortel L., Boutouyrie P., Giannattasio C., Hayoz D., Pannier B., Vlachopoulos C., Wilkinson I., Struijker-Boudier H. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur. Heart J. 2006, 27:2588-2605. European Network for Non-invasive Investigation of Large Arteries.
30. Lehoux S., Tedgui A. Making up and breaking up: the tortuous ways of the vascular wall. Arterioscler. Thromb. Vasc. Biol. 2005, 25:892-894.
31. Lehoux S., Esposito B., Merval R., Tedgui A. Differential regulation of vascular focal adhesion kinase by steady stretch and pulsatility. Circulation 2005, 111:643-649. 10.1161/01.CIR.0000154548.16191.2F.
32. London G.M., Asmar R.G., O'Rourke M.F., Safar M.E. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J. Am. Coll. Cardiol. 2004, 43:92-99. REASON Project Investigators.
33. Lu F.P., Lin K.P., Kuo H.K. Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS One 2009, 4:e4144.
34. Melzer D., Ely M., Brayne C. Cognitive impairment in elderly people: population based estimate of the future in England, Scotland, and Wales. BMJ 1997, 315:462.
35. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br. Med. J. 1992, 304:405-412. MRC Working Party.
36. Najjar S.S., Scuteri A., Lakatta E.G. Arterial aging: is it an immutable cardiovascular risk factor?. Hypertension 2005, 46:454-462.
37. Najjar S.S., Scuteri A., Shetty V., Wright J.G., Muller D.C., Fleg J.L., Spurgeon H.P., Ferrucci L., Lakatta E.G. Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore Longitudinal Study of Aging. J. Am. Coll. Cardiol. 2008, 51:1377-1383.
38. Nilsson P.M., Lurbe E., Laurent S. The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome. J. Hypertens. 2008, 26:1049-1057.
39. Nilsson P.M., Boutouyrie P., Laurent S. Vascular aging: a tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension 2009, 54:3-10.
40. Odden M.C., Coxson P.G., Moran A., Lightwood J.M., Goldman L., Bibbins-Domingo K. The impact of the aging population on coronary heart disease in the United States. Am. J. Med. 2011, 124:827-833.
41. Pauly R.R., Passaniti A., Bilato C., Monticone R., Cheng L., Papadopoulos N., Gluzband Y.A., Smith L., Weinstein C., Lakatta E.G., Crow M.T. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ. Res. 1994, 75:41-54.
42. Pilia G., Chen W.M., Scuteri A., Orru M., Albai G., Dei M., Lai S., Usala G., Lai M., Loi P., Mameli C., Vacca L., Deiana M., Olla N., Masala M., Cao A., Najjar S.S., Terracciano A., Nedorezov T., Sharov A., Zonderman A.B., Abecasis G.R., Costa P., Lakatta E.G., Schlessinger D. Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet. 2006, 2:e132-e148.
43. Raji C.A., Ho A.J., Parikshak N.N., Becker J.T., Lopez O.L., Kuller L.H., Hua X., Leow A.D., Toga A.W., Thompson P.M. Brain structure and obesity. Hum. Brain Mapp. 2010, 31:353-364.
44. Saydah S.H., Eberhardt M.S., Loria C.M., Brancati F.L. Age and the burden of death attributable to diabetes in the United States. Am. J. Epidemiol. 2002, 156:714-719.
45. Scuteri A. Slowing arterial aging: how far have we progressed?. J. Hypertens. 2007, 25:509-510.
46. Scuteri A., Jensen P.E., Aalkjaer C. Regulation of intracellular pH in resistance arteries of WKY and SHR - role of bicarbonate. J. Hypertens. 1995, 13:523-528.
47. Scuteri A., Chen C.H., Yin F.C.P., Chih T.T., Spurgeon H.A., Lakatta E.G. Functional correlates of central arterial geometric phenotypes. Hypertension 2001, 38:1471-1475.
48. Scuteri A., Najjar S.S., Muller D.C., Andres R., Hougaku H., Metter E.J., Lakatta E.G. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. JACC 2004, 43:1388-1395.
49. Scuteri A., Manolio T.A., Marino E.K., Arnold A.M., Lakatta E.G. Prevalence of specific variant carotid geometric patterns and incidence of cardiovascular events in older persons. The Cardiovascular Health Study. JACC 2004, 43:187-193.
50. Scuteri A., Najjar S.S., Morrell C.H., Lakatta E.G. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study. Diabetes Care 2005, 28:882-887.
51. Scuteri A., Palmieri L., Lo Noce C., Giampaoli S. Age-related changes in brain functions: cognition, executive process, and motor speed. A population-based study. Aging Clin. Exp. Res. 2005, 17:367-373.
52. Scuteri A., Tesauro M., Rizza S., Iantorno M., Federici M., Lauro D., Campia U., Turriziani M., Fusco A., Cocciolillo G., Lauro R. Endothelial dysfunction and arterial stiffness in normotensive normoglycemic first degree relatives of diabetic patients are independent of the metabolic syndrome. Nutr. Metab. Cardiovasc. Dis. 2008, 18:349-356.
53. Scuteri A., Coluccia R., Castello L., Nevola E., Brancati A.M., Volpe M. Left ventricular mass increase is associated with cognitive decline and dementia in the elderly independently of blood pressure. Eur. Heart J. 2009, 30:1525-1529.
54. Scuteri A., Najjar S.S., Orru' M., Albai G., Strait J., Tarasov K.V., Piras M.G., Cao A., Schlessinger D., Uda M., Lakatta E.G. Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: The SardiNIA Study. Nutr. Metab. Cardiovasc. Dis. 2009, 19:532-541.
55. Scuteri A., Najjar S.S., Orru' M., Usala G., Piras M.G., Ferrucci L., Cao A., Schlessinger D., Uda M., Lakatta E.G. The central arterial burden of the metabolic syndrome is similar in men and women: the SardiNIA Study. Eur. Heart J. 2010, 31:602-613.
56. Scuteri A., Orru' M., Morrell C.H., Piras M.G., Taub D., Schlessinger D., Uda M., Lakatta E.G. Independent and additive effects of cytokine patterns and the metabolic syndrome on arterial aging in the SardiNIA Study. Atherosclerosis 2011, 215:459-464.
57. Scuteri A., Nilsson P.M., Tzourio C., Redon J., Laurent S. Microvascular brain damage with aging and hypertension: pathophysiological consideration and clinical implications. J. Hypertens. 2011, 29:1469-1477.
58. Scuteri A., Castello L., Coluccia R., Modestino A., Nevola E., Volpe M. Depression is associated with increased occurrence of left ventricle concentric geometry in older subjects independently of blood pressure levels. Nutr. Metab. Cardiovasc. Dis. 2011, 21:915-921. (2010 Jul 31, Electronic publication ahead of print).
59. Scuteri A., Orru' M., Morrell C.H., Tarasov K., Schlessinger D., Uda M., Lakatta E.G. Associations of large artery structure and function with adiposity: effects of age, gender, and hypertension. The SardiNIA Study. Atherosclerosis 2012, 221:189-197. (2011 Dec 14, Electronic publication ahead of print).
60. Scuteri A., Modestino A., Frattari A., Di Daniele N., Tesauro M. Occurrence of hypotension in older participants. Which 24-hour ABPM parameter better correlate with?. J. Gerontol. A Biol. Sci. Med. Sci. 2012, (2012 Jan 6, Electronic publication ahead of print).
61. Selvetella G., Notte A., Maffei A., Calistri V., Scamardella V., Frati G., Trimarco B., Colonnese C., Lembo G. Left ventricular hypertrophy is associated with asymptomatic cerebral damage in hypertensive patients. Stroke 2003, 34:1766-1770.
62. Sinclair A. Available at:. http://www.instituteofdiabetes.org/wp-content/themes/IDOP/other/diabetes_guidelines_for_older_people.pdf.
63. Slotwiner D.J., Devereux R.B., Schwartz J.E., Pickering T.G., de Simone G., Ganau A., Saba P.S., Roman M.J. Relation of age to left ventricular function in clinically normal adults. Am. J. Cardiol. 1998, 82:621-626.
64. Sutton-Tyrrell K., Wildman R., Newman A., Kuller L.H. Extent of cardiovascular risk reduction associated with treatment of isolated systolic hypertension. Arch. Intern. Med. 2003, 163:2728-2731.
65. Takeda S., Sato N., Takeuchi D., Kurinami H., Shinohara M., Niisato K., et al. Angiotensin receptor blocker prevented beta-amyloid induced cognitive impairment associated with recovery of neurovascular coupling. Hypertension 2009, 54:1345-1352.
66. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Principal results of the Conduit Artery Function Evaluation (CAFÉ) Study. Circulation 2006, 113:1213-1225. The CAFÉ Investigators, for the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Investigators.
67. Arch. Intern. Med. 1997, 157:2413-2446. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
68. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N. Engl. J. Med. 2010, 362:1575-1585. The ACCORD Study Group.
69. Wang M., Zhang J., Spinetti G., Jiang L.Q., Monticone R., Zhao D., et al. Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats. Am. J. Pathol. 2005, 167:1429-1442.
70. Wang Y.R., Alexander G.C., Stafford R.S. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch. Intern. Med. 2007, 167:141-147.
71. Wang M., Khazan B., Lakatta E.G. Central arterial aging and angiotensin II signaling. Curr. Hypertens. Rev. 2010, 6:266-281.